BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Down 36.2% in March

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 233,600 shares, a decrease of 36.2% from the February 28th total of 366,100 shares. Currently, 2.1% of the shares of the stock are sold short. Based on an average trading volume of 3,480,000 shares, the short-interest ratio is currently 0.1 days.

BioNexus Gene Lab Trading Down 16.4 %

NASDAQ BGLC opened at $0.25 on Friday. The company’s 50 day simple moving average is $0.35 and its two-hundred day simple moving average is $0.35. BioNexus Gene Lab has a 1 year low of $0.21 and a 1 year high of $1.00.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.